TEXTMEDS – TEXT Messages To Improve MEDication Adherence And Secondary Prevention
Funder
National Health and Medical Research Council
Funding Amount
$1,406,875.00
Summary
TEXTMEDS will evaluate a highly innovative strategy to improve cardiovascular disease secondary prevention using cheap and widely available mobile phone technology. TEXTMEDS is a randomised controlled trial of 1400 patients with acute coronary syndrome that will examine the effect of a semi-personalised secondary prevention support program sent via mobile phone text message on the proportion taking appropriate medications for the secondary prevention of cardiovascular disease and on cardiovascul ....TEXTMEDS will evaluate a highly innovative strategy to improve cardiovascular disease secondary prevention using cheap and widely available mobile phone technology. TEXTMEDS is a randomised controlled trial of 1400 patients with acute coronary syndrome that will examine the effect of a semi-personalised secondary prevention support program sent via mobile phone text message on the proportion taking appropriate medications for the secondary prevention of cardiovascular disease and on cardiovascular risk factors levels (e.g. cholesterol).Read moreRead less
Secondary Prevention – Increasing Uptake And Engagement To Reduce Cardiovascular Events
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
Cardiovascular disease is a common and long-term health problem. Dr Redfern will continue to develop new and existing strategies for increasing uptake of and adherence to long-term behavioural change by people living with heart disease. The work will encompass policy development and media campaigns as well as trialling electronic communication systems such as text messaging and smart phone applications and new approaches including providing incentives for people who enact healthy behaviours.